Mycophenolate mofetil with or without tracolimus (FK506) as a second line treatment for steroid-resistant acute graft-versus-host disease.: The experience of Saint Louis Hospital

被引：0
|
作者：
Fisher, G. [1 ]
Rocha, V. [1 ]
Dos Santos, M. [1 ]
Devergie, A. [1 ]
Robin, M. [1 ]
de Latour, R. Peffault [1 ]
Ribaud, P. [1 ]
Ferry, C. [1 ]
Gluckman, E. [1 ]
Socie, G. [1 ]
机构：
[1] Hop St Louis, Paris, France
来源：
BONE MARROW TRANSPLANTATION | 2007年 / 39卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S107 / S107
页数：1
相关论文
共 50 条
  • [31] Alemtuzumab in the treatment of steroid refractory acute Graft-versus-Host Disease.
    Gomez-Almaguer, David
    Ruiz-Arguelles, Guillermo
    Gonzalez-Llano, Oscar
    Cantu, Olga G.
    Gutierrez, Cesar H.
    Jaime-Perez, Jose Carlos
    Tarin-Arzaga, Luz
    Giralt, Sergio
    BLOOD, 2006, 108 (11) : 415B - 416B
  • [32] FK506 FOR THE TREATMENT OF GRAFT-VERSUS-HOST DISEASE IN PATIENTS WHO RECEIVED CYCLOSPORINE AS THE PROPHYLAXIS OR THERAPY
    KANAMARU, A
    HIRAOKA, A
    DOHY, H
    KODERA, Y
    MORIYAMA, Y
    OKAMOTO, S
    MASAOKA, T
    EXPERIMENTAL HEMATOLOGY, 1993, 21 (08) : 1067 - 1067
  • [33] ALPHA-1-ANTITRYPSIN TREATMENT OF STEROID-RESISTANT ACUTE AND CHRONIC GRAFT-VERSUS-HOST DISEASE, SINGLE CENTER EXPERIENCE
    Guner, Sebnem Izmir
    BONE MARROW TRANSPLANTATION, 2024, 59 : 339 - 340
  • [34] Treatment of steroid-resistant Graft-versus-Host disease with monoclonal antibodies in children.
    Schechter, Tal
    Afzal, Samina
    Finkelstein, Yaron
    Koren, Gideon
    Doyle, John
    Dupuis, Laura Lee
    BLOOD, 2006, 108 (11) : 419B - 420B
  • [35] Infliximab as treatment for steroid refractory acute and chronic graft-versus-host disease.
    Trenschel, R
    Ditschkowski, M
    Biersack, H
    Trampenau, C
    Steckel, NK
    Peceny, R
    Ottinger, H
    Elmaagacli, A
    Scheulen, ME
    Beelen, DW
    Schaefer, UW
    BLOOD, 2002, 100 (11) : 450B - 450B
  • [36] Efficacy and safety of early administration of mycophenolate mofetil to steroid-resistant acute graft-versus-host disease after hematopoietic stem cell transplantation: A single institution study
    Mori, Masaki
    Muroi, Kazuo
    Matsuyama, Tomohiro
    Oka, Satoko
    Yamamoto, Chizuru
    Ozawa, Keiya
    BLOOD, 2007, 110 (11) : 327B - 327B
  • [37] Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut
    Kakihana, Kazuhiko
    Fujioka, Yuki
    Suda, Wataru
    Najima, Yuho
    Kuwata, Go
    Sasajima, Satoshi
    Mimura, Iyo
    Morita, Hidetoshi
    Sugiyama, Daisuke
    Nishikawa, Hiroyoshi
    Hattori, Masahira
    Hino, Yutaro
    Ikegawa, Shuntaro
    Yamamoto, Keita
    Toya, Takashi
    Doki, Noriko
    Koizumi, Koichi
    Honda, Kenya
    Ohashi, Kazuteru
    BLOOD, 2016, 128 (16) : 2083 - 2088
  • [38] OKT3 muromonab as second-line and subsequent treatment in recipients of stem cell allografts with steroid-resistant acute graft-versus-host disease
    Knop, S
    Hebart, H
    Gscheidle, H
    Holler, E
    Kolb, HJ
    Niederwieser, D
    Einsele, H
    BONE MARROW TRANSPLANTATION, 2005, 36 (09) : 831 - 837
  • [39] OKT3 muromonab as second-line and subsequent treatment in recipients of stem cell allografts with steroid-resistant acute graft-versus-host disease
    S Knop
    H Hebart
    H Gscheidle
    E Holler
    H-J Kolb
    D Niederwieser
    H Einsele
    Bone Marrow Transplantation, 2005, 36 : 831 - 837
  • [40] Salvage treatment with infliximab of steroid-resistant graft-versus-host disease in allogeneic transplanted patients
    Motllo, Cristina
    Ferra, Christelle
    Lopez, Laia
    Morgades, Mireia
    Batlle, Montserrat
    Maria Ribera, Josep
    MEDICINA CLINICA, 2011, 137 (03): : 115 - 118
12345